Regular physical exercise can prevent and/or ameliorate many diseases including type 2 diabetes and heart disease. These beneficial effects are partially the consequence of improved glucose and lipid homeostasis in peripheral tissues, especially skeletal muscle. The overall goal of this project is to determine the underlying molecular signaling mechanisms through which physical exercise regulates skeletal muscle glucose metabolism. In people with type 2 diabetes, skeletal muscles are typically insulin resistant, whereas the effects of exercise on glucose transport are preserved, perhaps due to distinct proximal signaling events leading to insulin- and contraction-stimulated glucose transport. At present, the precise nature of the contraction-stimulated signals remains obscure. However, the current hypothesis is that multiple signaling mechanisms mediate contraction-stimulated glucose transport.
Specific Aim 1 will determine the effects of members of the Ca2????dependent protein kinase (CaMK) family on contraction-stimulated glucose uptake.
Specific Aim 2 is designed to explore the role of atypical isoforms of protein kinase C (aPKC) on skeletal muscle glucose uptake. For both Aims 1 and 2, members of these signaling networks will be selectively activated and inhibited by using a powerful in vivo gene transfer model and muscle specific knockout mice, and their resultant effects on glucose transport will then be evaluated.
Specific Aim 3 proposes to look downstream of these signals to study whether multiple contraction-stimulated pathways converge at the Akt substrate of 160 kDa (AS160) and TBC1D1, leading to increased glucose transport.
This aim will employ site directed mutagenesis and in vivo gene transfer to pinpoint novel mechanisms for AS160 and TBC1D1 regulation of glucose transport. Collectively, these studies will significantly enhance the understanding of contraction-induced alterations in skeletal muscle glucose metabolism.

Public Health Relevance

Studies designed to understand how exercise alleviates the insulin resistance associated with type 2 diabetes is relevant to public health because type 2 diabetes is pervading virtually every demographic subset, with conspicuous and alarming affinity for younger individuals. Fortunately, physical exercise represents a cornerstone therapy to prevent or improve diabetes and its related pathologies. The goal of this proposal is to determine the molecular basis for these beneficial effects in exercising muscles, which may then be used to develop breakthrough drugs designed to treat diabetes.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-MOSS-L (07))
Program Officer
Boyce, Amanda T
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Joslin Diabetes Center
United States
Zip Code
Sinha, Manisha; Jang, Young C; Oh, Juhyun et al. (2014) Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344:649-52
Manabe, Yasuko; Gollisch, Katja S C; Holton, Laura et al. (2013) Exercise training-induced adaptations associated with increases in skeletal muscle glycogen content. FEBS J 280:916-26
Friedrichsen, Martin; Birk, Jesper B; Richter, Erik A et al. (2013) Akt2 influences glycogen synthase activity in human skeletal muscle through regulation of NHýýý-terminal (sites 2 + 2a) phosphorylation. Am J Physiol Endocrinol Metab 304:E631-9
Olesen, Jesper; Ringholm, Stine; Nielsen, Maja M et al. (2013) Role of PGC-1* in exercise training- and resveratrol-induced prevention of age-associated inflammation. Exp Gerontol 48:1274-84
Lessard, Sarah J; Rivas, Donato A; Alves-Wagner, Ana B et al. (2013) Resistance to aerobic exercise training causes metabolic dysfunction and reveals novel exercise-regulated signaling networks. Diabetes 62:2717-27
Jessen, Niels; An, Ding; Lihn, Aina S et al. (2011) Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301:E164-71
Toyoda, Taro; An, Ding; Witczak, Carol A et al. (2011) Myo1c regulates glucose uptake in mouse skeletal muscle. J Biol Chem 286:4133-40
Treebak, Jonas T; Taylor, Eric B; Witczak, Carol A et al. (2010) Identification of a novel phosphorylation site on TBC1D4 regulated by AMP-activated protein kinase in skeletal muscle. Am J Physiol Cell Physiol 298:C377-85
Witczak, Carol A; Jessen, Niels; Warro, Daniel M et al. (2010) CaMKII regulates contraction- but not insulin-induced glucose uptake in mouse skeletal muscle. Am J Physiol Endocrinol Metab 298:E1150-60
An, Ding; Toyoda, Taro; Taylor, Eric B et al. (2010) TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle. Diabetes 59:1358-65

Showing the most recent 10 out of 21 publications